A two-vaccine immunotherapy targeting T-cell receptors and tumor-specific mutations improved tumor control and survival in preclinical models, offering a potential new strategy against ...

BTK inhibitor monotherapy is foundational across several B-cell malignancies, with newer, more selective agents designed to preserve efficacy while improving tolerability relative to first-in-class ...

Detailed price information for Citius Oncology Inc (CTOR-Q) from The Globe and Mail including charting and trades.

Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can "educate" the immune system to find and destroy disease-causing cells throughout ...

I was diagnosed with cholangiocarcinoma, or cancer of the bile duct. As far as cancers go, it’s an especially brutal one: The five-year survival rate is around 10 percent, and most people diagnosed ...

In the fall of 2022, when I was 42 and living with my wife and three young kids in a small town in northwest Minnesota, a specialist at an unfamiliar hospital approached us with some test results. He ...

Epcoritamab plus R-DHAX/C achieved 79% ORR and 69% CR, with median 1.4 months to response and early activity evident by the first week-6 assessment. Over half of patients reached ASCT after ...

Twenty-seven year old Louth man Niall Breen knows only too well the pain that cancer can bring to families and also the support that the Irish Cancer Society provides when most needed. Niall, who lost ...

Vidac Pharma Holdings Plc. announces that in order to accelerate the development efforts of Vidac Pharma Holding PLC (“Company”), certain shareholders and directors of the Company have expressed their ...

A Parkersburg man who served in Vietnam has written a sequel to his first book with the expanded title of “Johnny Come Crumbling Home with PTSD and the Effects of Agent Orange.” John Danielski said ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 11:00 AM EDTCompany ParticipantsAndrew Dickinson - ...

Cancers emerge from many different paths. One path begins early, in embryonic development, when a protein complex called PRC2, which regulates cell differentiation, identity, and plasticity, becomes ...